Inspire Medical Systems, Inc. Share Price

Equities

INSP

US4577301090

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 17/05/2024 am IST 5-day change 1st Jan Change
159 USD -0.45% Intraday chart for Inspire Medical Systems, Inc. -8.80% -21.83%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 788M 65.78B Sales 2025 * 951M 79.38B Capitalization 4.72B 394B
Net income 2024 * 5M 417M Net income 2025 * 27M 2.25B EV / Sales 2024 * 5.44 x
Net cash position 2024 * 440M 36.72B Net cash position 2025 * 543M 45.33B EV / Sales 2025 * 4.4 x
P/E ratio 2024 *
968 x
P/E ratio 2025 *
184 x
Employees 1,011
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.45%
1 week-8.80%
Current month-34.19%
1 month-28.25%
3 months-17.52%
6 months+10.95%
Current year-21.83%
More quotes
1 week
155.01
Extreme 155.01
169.98
1 month
155.01
Extreme 155.01
257.40
Current year
155.01
Extreme 155.01
257.40
1 year
123.27
Extreme 123.27
330.00
3 years
123.27
Extreme 123.27
330.00
5 years
40.53
Extreme 40.53
330.00
10 years
22.50
Extreme 22.5
330.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/07/01
Director of Finance/CFO 56 16/14/16
Chief Tech/Sci/R&D Officer 61 28/22/28
Members of the board TitleAgeSince
Director/Board Member 66 25/19/25
Director/Board Member 64 01/08/01
Director/Board Member 66 01/08/01
More insiders
Date Price Change Volume
16/24/16 159 -0.45% 449,430
15/24/15 159.8 +0.73% 777,620
14/24/14 158.6 -0.63% 695,845
13/24/13 159.6 -4.90% 1,039,968
10/24/10 167.8 -3.75% 896,826

Delayed Quote Nyse, May 17, 2024 at 01:30 am IST

More quotes
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
159 USD
Average target price
250.7 USD
Spread / Average Target
+57.66%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW